Main menu

Targeting and comprehensive characterization of pharmacogenes using Oxford Nanopore Technologies’ adaptive sampling


Pharmacogenomics (PGx) is the study of how a person’s genome affects drug response. Adaptive sampling (AS) is a fast, flexible, and precise method to enrich for regions of interest by depleting off-target regions during sequencing itself, with no enrichment required during sample preparation.

Here, we demonstrate enrichment via adaptive sampling of a PGx gene panel with >278 unique pharmacogenetic targets sourced from the FDA, PharmGKB, and the Clinical Pharmacogenetics Implementation Consortium (CPIC).

Samples were analyzed using the wf-human-variation Epi2Me Labs pipeline from Oxford Nanopore Technologies, which called small variants with Clair3, structural variants with Sniffles2, and phased reads with whatshap. We show that coverage is sufficiently high for high accuracy star (*) allele calls on five samples multiplexed on a single flow cell.

Download the PDF

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag